Danaher Corporation logo

Danaher Corporation (DAP)

Market Closed
29 Jul, 20:00
176. 16
+0.8
+0.46%
178.45B Market Cap
28.65 P/E Ratio
1.08% Div Yield
15 Volume
7.58 Eps
175.36
Previous Close
Day Range
175.06 176.16
Year Range
155.22 258.05
Want to track DAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 82 days

Summary

DAP closed today higher at €176.16, an increase of 0.46% from yesterday's close, completing a monthly increase of 5.4% or €9.02. Over the past 12 months, DAP stock lost -20.47%.
DAP pays dividends to its shareholders, with the most recent payment made on Jul 25, 2025. The next estimated payment will be in In 2 months on Oct 25, 2025 for a total of €0.32.
The last earnings report, released on Jul 22, 2025, missed the consensus estimates by -1.64%. On average, the company has fell short of earnings expectations by -0.55%, based on the last three reports. The next scheduled earnings report is due on Oct 20, 2025.
Danaher Corporation has completed 7 stock splits, with the recent split occurring on Oct 02, 2023.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on NYSE (USD).

DAP Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
International Markets and Danaher (DHR): A Deep Dive for Investors

International Markets and Danaher (DHR): A Deep Dive for Investors

Explore how Danaher's (DHR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Zacks | 1 day ago
Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

'Mad Money' host Jim Cramer talks how to play Danaher after earnings.

Youtube | 5 days ago
Danaher Q2 2025 Update

Danaher Q2 2025 Update

While the worst seem to be behind them, the business isn't quite humming enough to get investors excited yet. Revenue growth guidance for 2025 remains unchanged at 3%. But they did raise full year adjusted diluted net EPS guidance to a range of $7.70 to $7.80 vs previous range of $7.60 to $7.75. Compared to the past few years, Danaher's multiples have noticeably come down. However, it is hard for a stock to go up if revenue growth hovers around LSD level.

Seekingalpha | 5 days ago

Danaher Corporation Dividends

Danaher Corporation logo
DAP 1 month ago
Other
€0.27 Per Share
Danaher Corporation logo
DAP 4 months ago
Other
€0.27 Per Share
Danaher Corporation logo
DAP 7 months ago
Other
€0.23 Per Share
Danaher Corporation logo
DAP 10 months ago
Other
€0.23 Per Share
Danaher Corporation logo
DAP 28 Jun 2024
Other
€0.23 Per Share

Danaher Corporation Earnings

21 Oct 2025 (In 2 months) Date
1.73
Cons. EPS
-
EPS
20 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
22 Jul 2025 Date
1.64
Cons. EPS
-
EPS
21 Jul 2025 Date
-
Cons. EPS
-
EPS
22 Apr 2025 Date
-
Cons. EPS
-
EPS
Danaher Corporation logo
DAP 1 month ago
Other
€0.27 Per Share
Danaher Corporation logo
DAP 4 months ago
Other
€0.27 Per Share
Danaher Corporation logo
DAP 7 months ago
Other
€0.23 Per Share
Danaher Corporation logo
DAP 10 months ago
Other
€0.23 Per Share
Danaher Corporation logo
DAP 28 Jun 2024
Other
€0.23 Per Share
21 Oct 2025 (In 2 months) Date
1.73
Cons. EPS
-
EPS
20 Oct 2025 (In 2 months) Date
-
Cons. EPS
-
EPS
22 Jul 2025 Date
1.64
Cons. EPS
-
EPS
21 Jul 2025 Date
-
Cons. EPS
-
EPS
22 Apr 2025 Date
-
Cons. EPS
-
EPS

Danaher Corporation (DAP) FAQ

What is the stock price today?

The current price is €176.16.

On which exchange is it traded?

Danaher Corporation is listed on NYSE.

What is its stock symbol?

The ticker symbol is DAP.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.08%.

What is its market cap?

As of today, the market cap is 178.45B.

When is the next earnings date?

The next earnings report will release on Oct 20, 2025.

Has Danaher Corporation ever had a stock split?

Danaher Corporation had 7 splits and the recent split was on Oct 02, 2023.

Danaher Corporation Profile

Medical - Diagnostics & Research Industry
Healthcare Sector
Rainer M. Blair CEO
XBER Exchange
US2358511028 ISIN
US Country
61,000 Employees
28 Mar 2025 Last Dividend
2 Oct 2023 Last Split
5 Jan 1979 IPO Date

Overview

Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.

Products and Services

  • Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
  • Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
  • Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.

Contact Information

Address: 2200 Pennsylvania Avenue, NW
Phone: 202 828 0850